论文部分内容阅读
选取2012年6月~2014年6月我院门诊收治的功能性消化不良(FD)患者共108例,按照随机的原则将其分为对照组和观察组各54例,其中对照组给予莫沙比利和雷贝拉唑进行治疗,观察组在对照组治疗基础上给予氟哌噻吨美利曲辛片进行治疗,治疗疗程8w,治疗前后采用肠道症状评定量表(GSRS)对患者临床治疗效果进行评价对比。评定结果显示,观察组患者治疗后GSRS评分较对照组低。对照组中治疗显效10例,有效23例,无效21例,总有效率为61.1%;对照组中治疗显效17例,有效31例,无效6例,总有效率为88.9%,组间对比差异有统计学意义(P<0.05)。氟哌噻吨美利曲辛片作为一种重要的辅助药物,在治疗功能性消化不良中疗效显著,无明显不良反应,值得在临床上进行推广和应用。
A total of 108 patients with functional dyspepsia (FD) admitted from our hospital from June 2012 to June 2014 were randomly divided into control group and observation group (n = 54). The control group was given Mosai Billy and rabeprazole treatment, the observation group was given flupentixol and melitracen tablets on the basis of the treatment of the control group. The course of treatment was 8 weeks. The clinical symptoms of the patients were treated with GSRS Evaluation of the effect of contrast. Assessment results showed that patients in the observation group after treatment GSRS score lower than the control group. In the control group, 10 cases were markedly effective, 23 cases were effective, 21 cases were ineffective and the total effective rate was 61.1%. In the control group, 17 cases were markedly effective, 31 cases were effective and 6 cases were ineffective. The total effective rate was 88.9% There was statistical significance (P <0.05). Flupentixol MTV as an important auxiliary drug in the treatment of functional dyspepsia significant effect, no significant adverse reactions, it is worth in the clinical promotion and application.